Opioid maker Insys to be delisted from NASDAQ following bankruptcy filing

OxyContin maker Purdue Pharma LP will ask a U.S. Bankruptcy Judge on Friday to pause litigation against the company and its owners over the objections of U.S. states that allege the company is trying to protect the controlling Sackler family......»»

A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid battling over the deal's billions of dollars......»»

The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal," according to a court filing on Monday......»»

Tesla Inc (NASDAQ: TSLA) has acquired an Ontario battery manufacturer, Hibar Systems Limited, according to a filing with regulators.  read more.....»»

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel the U.S. opioid crisis, according to court documents......»»

A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis......»»

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis......»»

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis......»»

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis......»»

Purdue Pharma, the narcotics manufacturer blamed for triggering America’s opioid crisis through its aggressive marketing of the highly addictive painkiller OxyContin, filed for bankruptcy Sunday......»»

Purdue Pharma, the company behind OxyContin, filed for bankruptcy protection Sunday night (September 15), amid more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic. Ryan Brooks reports......»»

OxyContin maker Purdue Pharma LP filed for bankruptcy protection in New York Sunday night, succumbing to pressure from more than 2,000 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

OxyContin maker Purdue Pharma is nearing a partial.....»»

OxyContin maker Purdue Pharma is nearing a partial.....»»

Insys Therapeutics Inc, has entered into sales agreements to unload some of its drug assets for a combined $29.2 million as the Chandler-based pharmaceutical firm works through bankruptcy filing proceedings. Insys will sell its naloxone and epinephrin.....»»

T.....»»

Legacy Reserves Inc (NASDAQ: LGCY) has made a Chapter 11 filing in the U.S. Bankruptcy Court for the Southern District of Texas. read more.....»»

The moves comes one week after the company agreed to pay $225 million to resolve a federal investigation into a bribery scheme designed to induce doctors to overprescribe a fentanyl spray......»»

The moves comes one week after the company agreed to pay $225 million to resolve a federal investigation into a bribery scheme designed to induce doctors to overprescribe a fentanyl spray......»»